DEVICE · Unmapped registry intervention
Polyglucosamine L112
Find medicine records ·
Find other trials using this name
Clinical trial
Influence of Polyglucosamine L112 on Serum Surrogate Markers of Cholesterol Absorption
NCT05038436
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedInfluence of Polyglucosamine L112 on Serum Surrogate Markers of Cholesterol Absorption
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Cholesterol Loweringunresolved
Interventions
Polyglucosamine L112DEVICE
Sponsors & collaborators
Certmedica International GmbHlead sponsor
University Hospital, Bonncollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05038436 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.